Mark Read departs WPP as the advertising industry grapples with agencies' declining power amid the rise of Big Tech and AI.

Dave’s journey into animation started at the age of 12 when he discovered that the popular cartoon, the Teenage Mutant Ninja ...

IT WAS just over a year ago when Nike’s then CEO, John Donahoe, trumpeted a flashy 90-second video, hyping a report about the ...

Extended follow-up data from the CheckMate 274 trial have further solidified adjuvant nivolumab’s position as a standard of ...

The United States was born in war and has waged a war of some sort in every year of its existence. Silicon Valley ...

A woman who said the contraceptive jab 'ruined her life' is among one of a number of others experiencing side effects who say they regret ever taking it.

Investors found in an 8-K filing by Intellia Therapeutics Inc. the news of one case of liver-enzyme elevation in the ongoing phase III Magnitude study with nexiguran ziclumeran (nex-z, NTLA-2001), and ...

US drugmaker Pfizer said it would license an experimental cancer treatment from China's 3SBio Inc, paying $1.25 billion upfront and up to another $4.8 billion if developmental milestones are met.

Pfizer Ltd has reported an 85% jump in net profit at ₹330.94 crore in the fourth quarter ended March 2025, boosted by a gain in exceptional item from completion of asset sale and transfer.

While Pfizer Ltd had reported Rs179 crore In the corresponding quarter of the previous fiscal, or March quarter of FY24, the net profit in the March 2025 quarter saw a sharp jump to ₹331 crore.

It did not take long for Pfizer Inc. (NYSE:PFE) to change its mind on its oncology pipeline approach – after the deal with Summit Therapeutics Inc. (SMMT) in February for co-development of ...